[go: up one dir, main page]

WO1998001125A3 - Isomeres dextrogyres d'oxybutynine et de desethyloxybutynine utilises dans le traitement de l'hyperactivite gastro-intestinale - Google Patents

Isomeres dextrogyres d'oxybutynine et de desethyloxybutynine utilises dans le traitement de l'hyperactivite gastro-intestinale Download PDF

Info

Publication number
WO1998001125A3
WO1998001125A3 PCT/US1997/012284 US9712284W WO9801125A3 WO 1998001125 A3 WO1998001125 A3 WO 1998001125A3 US 9712284 W US9712284 W US 9712284W WO 9801125 A3 WO9801125 A3 WO 9801125A3
Authority
WO
WIPO (PCT)
Prior art keywords
desethyloxybutynin
oxybutynin
treatment
dextrorotatory isomers
gastrointestinal hyperactivity
Prior art date
Application number
PCT/US1997/012284
Other languages
English (en)
Other versions
WO1998001125A2 (fr
Inventor
Gunnar Aberg
Original Assignee
Sepracor Inc
Gunnar Aberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc, Gunnar Aberg filed Critical Sepracor Inc
Priority to AU37999/97A priority Critical patent/AU3799997A/en
Publication of WO1998001125A2 publication Critical patent/WO1998001125A2/fr
Publication of WO1998001125A3 publication Critical patent/WO1998001125A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Cette invention concerne un procédé permettant de traiter l'hyperactivité gastro-intestinale, le syndrome du côlon irrité, ainsi que d'autres troubles de motilité liés aux voies gastro-intestinales. Ce procédé consiste à administrer une quantité efficace sur le plan thérapeutique de (S)-oxybutynine, de (S)-déséthyloxybutynine ou d'un de leurs sels acceptable sur le plan pharmaceutique, ces éléments ne comprenant quasiment pas d'énantiomère R correspondant.
PCT/US1997/012284 1996-07-09 1997-07-09 Isomeres dextrogyres d'oxybutynine et de desethyloxybutynine utilises dans le traitement de l'hyperactivite gastro-intestinale WO1998001125A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU37999/97A AU3799997A (en) 1996-07-09 1997-07-09 Dextrorotatory isomers of oxybutynin and desethyloxybutynin in the treatment of gastrointestinal hyperactivity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2140296P 1996-07-09 1996-07-09
US60/021,402 1996-07-09

Publications (2)

Publication Number Publication Date
WO1998001125A2 WO1998001125A2 (fr) 1998-01-15
WO1998001125A3 true WO1998001125A3 (fr) 1998-05-07

Family

ID=21804010

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/012284 WO1998001125A2 (fr) 1996-07-09 1997-07-09 Isomeres dextrogyres d'oxybutynine et de desethyloxybutynine utilises dans le traitement de l'hyperactivite gastro-intestinale

Country Status (2)

Country Link
AU (1) AU3799997A (fr)
WO (1) WO1998001125A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2371923A1 (fr) * 1999-05-20 2000-11-30 Thomas P. Jerussi Procedes de traitement de l'asthme a l'aide de s-oxybutynine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB940540A (en) * 1960-07-26 1963-10-30 Mead Johnson & Co Aminoacetylenes and process for preparing the same
WO1996012477A1 (fr) * 1994-10-21 1996-05-02 Leiras Oy Systeme d'administration orale a liberation lente contenant de l'oxybutynine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB940540A (en) * 1960-07-26 1963-10-30 Mead Johnson & Co Aminoacetylenes and process for preparing the same
WO1996012477A1 (fr) * 1994-10-21 1996-05-02 Leiras Oy Systeme d'administration orale a liberation lente contenant de l'oxybutynine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HUGHES, K.M. ET AL: "Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers", XENOBIOTICA, vol. 7, July 1992 (1992-07-01), pages 859 - 869, XP000572170 *
KACHUR, J.F. ET AL: "R and S enantiomers of Oxybutynin: Pharmacological effects in guinea pig bladder and intestine", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 247, no. 3, 1988, pages 867 - 872, XP000200584 *
NORONHA-BLOB, L. ET AL: "Enantiomers of Oxybutynin: In vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs", THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 256, no. 2, 1991, pages 562 - 67, XP000572006 *

Also Published As

Publication number Publication date
WO1998001125A2 (fr) 1998-01-15
AU3799997A (en) 1998-02-02

Similar Documents

Publication Publication Date Title
WO1999022721A3 (fr) Procede de traitement de l'hypercholesterolemie a l'aide de polydiallylamine non substituee
CA2259012A1 (fr) S(-)-tolterodine pour le traitement des troubles urinaires et gastro-intestinaux
EP1574219A3 (fr) Procédé d'inhibition de la fibrose avec un agoniste de la somatostatine
CA2180011A1 (fr) Toxines botulinum utilisees dans le traitement de divers troubles, et douleurs associees
EP1555025A3 (fr) Utilisation d'analogues de déhydroépiandrostérone pour le traitement de l'asthme
CA2272584A1 (fr) Nouveaux derives de pyrazole substitues pour le traitement de maladies cardio-vasculaires
NO973516L (no) Behandling av urininkontinens ved anvendelse av (S)-oksybutynin og (S)-desetyloksybutynin
CA2180535A1 (fr) Procede de traitement du psoriasis par omeprazole ou autres composes apparentes
EP1029540A3 (fr) Utilisation de la droloxifène pour le traitement de maladies cardiovasculaires
CA2391808A1 (fr) Procede de traitement de symptomes de troubles du systeme nerveux central
CA2255652A1 (fr) Isobutylgaba et ses derives utilises pour le traitement de la douleur
CA2304657A1 (fr) Traitement du trouble des conduites
CA2226582A1 (fr) Agonistes non allosteriques de gabaa destines a traiter des troubles du sommeil
WO1997009976A3 (fr) Procede d'attenuation de troubles dus a des neurotoxines par des chelatants du zinc
CA2353133A1 (fr) Traitement de troubles decoulant de deficiences organiques
CA2383785A1 (fr) Techniques d'utilisation d'inhibiteurs selectifs de recaptage de serotonine a apparition rapide pour traiter un dysfonctionnement sexuel
CA2283255A1 (fr) Utilisation d'enantiomeres r d'anti-inflammatoires non steroidiens pour la prevention de la maladie d'alzheimer
CA2061665A1 (fr) Traitement de troubles des voies urinaires inferieures
WO2000051582A3 (fr) Procedes de traitement de l'apnee et de troubles de l'apnee a l'aide de r(+) ondansetron optiquement pur
WO1999065475A3 (fr) Combinaison de phentolamine et apomorphine pour le traitement concernant les fonctions et les dysfonctionnements sexuels
WO1998001125A3 (fr) Isomeres dextrogyres d'oxybutynine et de desethyloxybutynine utilises dans le traitement de l'hyperactivite gastro-intestinale
RU96119673A (ru) Способ лечения болевого синдрома
CA2130563A1 (fr) Derive de 2,6-methano-2h-qinolizine, antagoniste du recepteur 5-ht3
WO2000044386A8 (fr) Procede de traitement des maux de tete
WO1999033454A3 (fr) Procyclidine-s aux fins du traitement de l'incontinence urinaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ

NENP Non-entry into the national phase

Ref country code: CA

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998505375

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase